Access to health care after COVID-19 pandemic: is it time for telemedicine?
Eur Rev Med Pharmacol Sci
.
2020 Oct;24(19):9778-9779.
doi: 10.26355/eurrev_202010_23185.
Authors
G Vanni
1
,
M Materazzo
,
M Pellicciaro
,
J Caspi
,
A Capacci
,
G Merra
Affiliation
1
Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy. giuseppe.merra@policlinicogemelli.it.
PMID:
33090451
DOI:
10.26355/eurrev_202010_23185
No abstract available
Publication types
Letter
MeSH terms
Breast Neoplasms / therapy*
COVID-19* / epidemiology
Female
Health Care Costs
Health Services Accessibility*
Humans
Pandemics
Telemedicine / economics
Telemedicine / trends*